Synergistic action of cisplatin and echistatin in MDA-MB-231 breast cancer cells
Author:
Funder
Medical University of Bialystok
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Clinical Biochemistry,Molecular Biology,General Medicine
Link
http://link.springer.com/content/pdf/10.1007/s11010-016-2894-8.pdf
Reference64 articles.
1. Desantis C, Siegel R, Bandi P, Jemal A (2011) Breast cancer statistics 2011. CA Cancer J Clin 61(6):409–418
2. Obel JC, Friberg G, Fleming GF (2006) Chemotherapy in endometrial cancer. Clin Adv Hematol Oncol 4(6):459–468
3. Hartmann JT, Fels LM, Knop S, Stolt H, Kanz L, Bokemeyer C (2000) A randomized trial comparing the nephrotoxicity of cisplatin/ifosfamide-based combination chemotherapy with or without amifostine in patients with solid tumors. Investig New Drugs 18:281–289
4. Hartmann JT, Lipp HP (2003) Toxicity of platinum compounds. Expert Opin Pharmacother 4(6):889–901
5. Iraz M, Ozerol E, Gulec M, Tasdemir S, Idiz N, Fadillioglu E, Naziroglu M, Akyol O (2006) Protective effect of caffeic acid phenethyl ester (CAPE) administration on cisplatin-induced oxidative damage to liver in rat. Cell Biochem Funct 24:357–361
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Synergistic effects of combined cisplatin and Clinacanthus nutans extract on triple negative breast cancer cells;Journal of Taibah University Medical Sciences;2023-12
2. Why to Study Peptides from Venomous and Poisonous Animals?;International Journal of Peptide Research and Therapeutics;2023-07-14
3. Anticancer activity and DNA interaction of bis(pyridyl)allene-derived metal complexes;Pure and Applied Chemistry;2023-04-01
4. Synthesis and Anti-Angiogenic Activity of Novel c(RGDyK) Peptide-Based JH-VII-139-1 Conjugates;Pharmaceutics;2023-01-22
5. Eribulin Mesylate Improves Cisplatin-Induced Cytotoxicity of Triple-Negative Breast Cancer by Extracellular Signal-Regulated Kinase 1/2 Activation;Medicina;2022-04-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3